Oxford Molecular: designer appeal

Article Abstract:

Oxford Molecular is a UK company licenses software used to design and test new products for the pharmaceutical industry, and has been affected by investors' disenchantment with UK biotech companies. The company should benefit from the acquisition of IntelliGenetics, a US firm, for 5 million pounds sterling in Aug 1994. The company sells technology to large drug firms, and also aims to boost revenue by performing tests for small drug firms on a contract basis. Oxford has promising potential for growth and the company's shares are recommended for investment.

Oxford Molecular Inc.

---

Overdose of hype at ML Labs

Article Abstract:

ML Laboratories is a UK medical products concern which has seen a rise in its share price in 1995, despite having reported losses over ten years of existence. The company's shares rose after reports of a successful HIV drug in 1995. The methods of the study have been questioned, and the results are based on only four patients. ML has other products such as Icodial, a kidney dialysis fluid, but the company is involved in legal action with Baxter over this product.

Biotechnology industry, Biotechnology industries, ML Laboratories

---

Healthcare looks buoyant

Article Abstract:

Opportunities for investors in the healthcare sector are examined in detail, and the sector is seen as offering good growth prospects.

Portfolio Management, Analysis, Economic aspects, Health care industry

Similar abstracts:

• Abstracts: Gene targeting using zinc finger nucleases. The small world of metabolism. Electrochemical DNA analysis comes of age
• Abstracts: Brave new world. Euro defence closes the gap. Aerospace, defence
• Abstracts: How to be an oil tycoon. Caspian deal comes with snags. Oil exploration
• Abstracts: The information superhighway: establishing your nexus. Databases: is there one in your practice management future?
• Abstracts: Better focus boosts prospects. Micro Focus. IS Solutions

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.